CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-02 | MIGAUSKY GEORGE V Director | Grant or award · Stock Options (Right to Buy) | +17,892 | 17,892 | ||
| 2023-06-02 | Glucksmann Alexandra Director | Grant or award | +3,486 | 6,496 | ||
| 2023-06-02 | Glucksmann Alexandra Director | Grant or award · Stock Options (Right to Buy) | +17,892 | 17,892 | ||
| 2023-06-02 | KARABELAS ARGERIS N Director | Grant or award | +3,486 | 6,496 | ||
| 2023-06-02 | KARABELAS ARGERIS N Director | Grant or award · Stock Options (Right to Buy) | +17,892 | 17,892 | ||
| 2023-06-02 | Bennett Jean Director | Grant or award | +3,486 | 6,496 | ||
| 2023-06-02 | Bennett Jean Director | Grant or award · Stock Options (Right to Buy) | +17,892 | 17,892 | ||
| 2023-06-02 | Zachary Jennifer Director | Grant or award | +3,486 | 9,506 | ||
| 2023-06-02 | Zachary Jennifer Director | Grant or award · Stock Options (Right to Buy) | +17,892 | 17,892 | ||
| 2023-05-31 | Vasista Vittal Chief Financial Officer | Option exercise | +35,000 | $0.85 | $30K | 215,001 |
| 2023-05-31 | Vasista Vittal Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2023-01-03 | Vasista Vittal Chief Financial Officer | Shares withheld for taxes | −1,333 | $22.68 | $30K | 133,827 |
| 2023-01-03 | Vasista Vittal Chief Financial Officer | Grant or award | +46,174 | 180,001 | ||
| 2023-01-03 | Vasista Vittal Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +66,233 | 66,233 | ||
| 2023-01-03 | Simpson Curran Chief Oper. & Tech. Officer | Shares withheld for taxes | −2,076 | $22.68 | $47K | 25,040 |
| 2023-01-03 | Simpson Curran Chief Oper. & Tech. Officer | Grant or award | +67,945 | 92,985 | ||
| 2023-01-03 | Simpson Curran Chief Oper. & Tech. Officer | Grant or award · Stock Options (Right to buy) | +52,986 | 52,986 | ||
| 2023-01-03 | PAKOLA STEVE Chief Medical Officer | Shares withheld for taxes | −1,837 | $22.68 | $42K | 15,313 |
| 2023-01-03 | PAKOLA STEVE Chief Medical Officer | Sale | −3,138 | $22.17 | $70K | 12,175 |
| 2023-01-03 | PAKOLA STEVE Chief Medical Officer | Grant or award | +90,588 | 102,763 |
Page 12 of 25 · 494 trades